title: Multiple sclerosis after allergen-specific immunotherapy and influenza vaccination.
authors.affiliation: Division of Neurology, First Department of Internal Medicine, Osaka Medical College, Takatsuki City, Japan. in1045@poh.osaka-med.ac.jp
authors.forename: Hideto
authors.initials: H
authors.lastname: Nakajima
authors.forename: Sizue
authors.initials: S
authors.lastname: Ohtsuka
authors.forename: Takuya
authors.initials: T
authors.lastname: Nishina
authors.forename: Masakazu
authors.initials: M
authors.lastname: Sugino
authors.forename: Fumiharu
authors.initials: F
authors.lastname: Kimura
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Hanafusa
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Ikemoto
authors.forename: Akira
authors.initials: A
authors.lastname: Shimizu
mesh_terms: D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D003888:Desensitization, Immunologic / Q000009:adverse effects*; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000139:chemically induced*; D054398:Receptors, CCR4; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine / Q000378:metabolism; D012220:Rhinitis / Q000276:immunology / Q000517:prevention & control; D013997:Time Factors; D014611:Vaccination
chemical_list: C515354:CCR4 protein, human; C515187:CXCR3 protein, human; D007252:Influenza Vaccines; D054398:Receptors, CCR4; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine